Search Results 201-210 of 11512 for Cirrhosis
In some cases, nonalcoholic fatty liver disease eventually can damage the liver to the point that cirrhosis develops. This serious and sometimes life- ...
The purpose of this study is to evaluate the outcome of hospitalization related to the presence of cirrhosis. We are participating in optional blood, saliva ...
Study To Evaluate The Safety And Effectiveness Of BMS-986036 In Adults With Nonalcoholic Steatophepatitis (NASH) And Compensated Liver Cirrhosis · Share ...
Leise, M.D.. Transplant Hepatologist. Rochester, MN. Areas of focus: Upper endoscopy, Colonoscopy, Hepatic encephalopathy, Hepatocellular carcinoma, Cirrhosis, ...
Stage D hepatocellular carcinoma means the liver is not healthy enough to have treatment. This is because cirrhosis is so severe. The healthcare team might ...
This is a Phase 3, randomized, double-blind, placebo-controlled study evaluating the clinical benefit and safety of EFX in subjects with compensated cirrhosis ...
... . Bloom, M.D., studies how the intestinal microbiome and impaired gut barrier function contribute to hepatic encephalopathy in people with cirrhosis.
Liver cirrhosis of any etiology. Diagnosis of cirrhosis based on at least one of the following criteria: Histology;; Imaging showing cirrhotic liver; ...
A Study Of The Safety, Tolerability, And Effectiveness Of GS-9674 For Adults With Primary Sclerosing Cholangitis Without Cirrhosis · More about research at Mayo ...
Post-operative Mortality Risk in Patients with Cirrhosis ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.